Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Month The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Benzinga · Aug 21, 2025
As low-nicotine cigarettes hit the market, anti-smoking groups press for wider standard The idea seems simple enough. Tribune News Service · Jul 6, 2023
22nd Century Group Q3 Revenue Grows 148% YoY, Here Are The Details 22nd Century Group, Inc. (NASDAQ: XXII) net revenues for the third quarter of 2022 were $19.4 million, an increase of 148.2% from 2021. Benzinga · Nov 8, 2022
Cannabis Movers & Shakers: 22nd Century Group, Houseplant, Proven Media 22nd Century Group Names New CFO 22nd Century Group (NASDAQ: XXII) has appointed f R. Hugh Kinsman to oversee its financial department. Kinsman is currently CFO of GVB Biopharma, which 22nd Century acquired effective May 13, 2022. Benzinga · Jun 17, 2022
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International Mind Medicine Names New CEO Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) has hired Schond L. Greenway to oversee its finance department. Benzinga · May 24, 2022
22nd Century Group Acquires Privately-Held Cannabis & Hemp Co., Here's What's Next 22nd Century Group, Inc. (NASDAQ: XXII) announced the acquisition of privately held GVB Biopharma. GVB - a contract development and manufacturing organization - provides hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide. Benzinga · May 13, 2022
22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows 22nd Century Group, Inc. (NASDAQ: XXII) reported results for the first quarter ended March 31, 2022.. The company will host a live audio webcast on May 5, at 10:00 a.m. ET. Benzinga · May 5, 2022
22nd Century Group Welcomes Dr. Robert Califf's Confirmation As FDA Commissioner 22nd Century Group, Inc. (NASDAQ: XXII) an agricultural biotechnology company focused on tobacco harm reduction, congratulated Dr. Benzinga · Feb 25, 2022
22nd Century Group And KeyGene Achieve Breakthrough In Hemp/Cannabis GMO Research 22nd Century Group, Inc. Benzinga · Feb 23, 2022
22nd Century Group To Host Q4 & FY 2021 Earnings Call 22nd Century Group, Inc. (NASDAQ: XXII) announced that it will host a live webcast on Tuesday, March 1, 2022, at 10:00 AM ET to discuss its 2021 fourth quarter and full year results. Benzinga · Feb 3, 2022